연구

연구업적

최근 5년 연구업적 현황
연도 2024년 2023년 2022년 2021년 2020년
SCI 논문
발표편수
책임 179편 173편 163편 184편 135편
공동 147편 120편 115편 136편 168편
합계 326편 293편 278편 320편 303편
1687. Glycosylation of Sodium/Iodide Symporter (NIS) Regulates Its Membrane Translocation and Radioiodine Uptake.
Chung T, Youn H, Yeom CJ, Kang KW, Chung JK.
PLoS One. 2015 Nov 23;10(11):e0142984 Link
1686. Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma.
Lee KH, Lee KB, Kim TY, Han SW, Oh DY, Im SA, Kim TY, Yi NJ, Lee KW, Suh KS, Jang JJ, Bang YJ.
BMC Cancer. 2015 Oct 16;15:721.? Link
1685. Comparison of 4D CT, ultrasonography, and 99mTc sestamibi SPECT/CT in localizing single-gland primary hyperparathyroidism.
Suh YJ1, Choi JY2, Kim SJ1, Chun IK3, Yun TJ4, Lee KE5, Kim JH4, Cheon GJ6, Youn YK1.
Otolaryngol Head Neck Surg. 2015 Mar;152(3):438-43. doi: 10.1177/0194599814562195. Epub 2014 Dec 17. Link
1684. Protocol of a thyroid cancer longitudinal study (T-CALOS): a prospective, clinical and epidemiological study in Korea.
Lee KE1, Park YJ2, Cho B3, Hwang Y4, Choi JY5, Kim SJ1, Choi H6, Choi HC3, An AR3, Park do J2, Park SK4, Youn YK7.
BMJ Open. 2015 Jan 5;5(1):e007234. doi: 10.1136/bmjopen-2014-007234. Link
1683. Factors Affecting the Locoregional Recurrence of Conventional Papillary Thyroid Carcinoma After Surgery: A Retrospective Analysis of 3381 Patients.
Suh YJ1,2, Kwon H1,2, Kim SJ1,2, Choi JY2,3, Lee KE4,5, Park YJ2,6, Park do J2,6, Youn YK1,2.
Ann Surg Oncol. 2015 Oct;22(11):3543-9. doi: 10.1245/s10434-015-4448-9. Epub 2015 Mar 6. Link
1682. Prospective, randomized controlled trial on use of ropivacaine after robotic thyroid surgery: Effects on postoperative pain.
Bae DS1, Kim SJ2, Koo DH1, Paek SH2, Kwon H2, Chai YJ3, Choi JY4, Lee KE2, Youn YK2.
Head Neck. 2015 Mar 17. doi: 10.1002/hed.24045. [Epub ahead of print] Link
1681. Optimal Cutoff Age for Predicting Mortality Associated with Differentiated Thyroid Cancer.
Kim SJ1, Myong JP2, Suh H3, Lee KE1, Youn YK1.
PLoS One. 2015 Jun 23;10(6):e0130848. doi: 10.1371/journal.pone.0130848. eCollection 2015. Link
1680. Aberrant Epigenetic Modifications of LPHN2 Function as a Potential Cisplatin-specific Biomarker for Human Gastrointestinal Cancer.
Jeon MS1,2, Song SH1, Yun J1,2, Kang JY1,2, Kim HP1, Han SW1,3, Kim TY1,2,3.
Cancer Res Treat. 2015 Sep 22. doi: 10.4143/crt.2015.153. [Epub ahead of print] Link
1679. Reduced cohesin destabilizes high-level gene amplification by disrupting pre-replication complex bindings in human cancers with chromosomal instability.
Yun J1, Song SH2, Kang JY1, Park J2, Kim HP1, Han SW3, Kim TY4.
Nucleic Acids Res. 2016 Jan 29;44(2):558-72. doi: 10.1093/nar/gkv933. Epub 2015 Sep 29. Link
1678. Disruption of CTCF/cohesin-mediated high-order chromatin structures by DNA methylation downregulates PTGS2 expression.
Kang JY1,2, Song SH1, Yun J1,2, Jeon MS1,2, Kim HP1, Han SW1,3, Kim TY1,2,3.
Oncogene. 2015 Nov 5;34(45):5677-84. doi: 10.1038/onc.2015.17. Epub 2015 Feb 23. Link